| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |